Negative diffusion-weighted imaging after intravenous tissue-type plasminogen activator is rare and unlikely to indicate averted infarction.

Authors

Jason W. Freeman, National Institute of Neurological Disorders and Stroke, Bethesda, MD
Marie Luby, National Institute of Neurological Disorders and Stroke, Bethesda, MD
Jose G. Merino, National Institutes of Health, Bethesda, MD
Lawrence L. Latour, National Institute of Neurological Disorders and Stroke, Bethesda, MD
Sungyoung Auh, National Institute of Neurological Disorders and Stroke, Bethesda, MD
Shlee S. Song, Cedars Sinai Medical Center
Alejandro Magadan, National Institute of Neurological Disorders and Stroke, Bethesda, MD
John K. Lynch, National Institute of Neurological Disorders and Stroke, Bethesda, MD
Steven Warach, National Institute of Neurological Disorders and Stroke, Bethesda, MD
Amie W. Hsia, Stroke Center, Medstar Washington Hospital Center

Document Type

Journal Article

Publication Date

6-2013

Journal

Stroke

Volume

Volume 44, Issue 6

Inclusive Pages

1629-1634

Comments

PMCID: PMC3690771 [Available on 2014/6/1]

APA Citation

Freeman, J. W., Luby, M., Merino, J. G., Latour, L. L., Auh, S., Song, S. S., . . . Hsia, A. W. (2013). Negative diffusion-weighted imaging after intravenous tissue-type plasminogen activator is rare and unlikely to indicate averted infarction. Stroke, 44(6), 1629-1634.

Peer Reviewed

1